Connect with us

EU

EU agrees VAT relief for vaccines and testing kits

SHARE:

Published

5 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The Commission has welcomed the adoption of important new measures which will enable member states to relieve EU hospitals, medical practitioners and individuals of  VAT when acquiring coronavirus vaccines and testing kits.

The new rules, adopted unanimously by all member states and based on a Commission proposal of 28 October (as part of the Communication on additional COVID-19 response measures), are designed to give better and cheaper access to the tools needed to prevent, detect and treat coronavirus.

Economy Commissioner Paolo Gentiloni  said: “The agreement will help ensure that coronavirus vaccines can be acquired VAT-free throughout the EU. I congratulate all involved for the extremely swift adoption of the new rules, which will help make both vaccines and testing kits cheaper. The successful roll-out of these vaccines is crucial for Europe to emerge from the shadow of the pandemic: it will be the number one priority for the coming months.”

The measures will allow EU countries to put in place a temporary VAT exemption for vaccines and testing kits being sold to hospitals, doctors and individuals, as well as closely related services. Currently, member states can apply reduced VAT rates on sales of vaccines but cannot apply a zero rate, while testing kits cannot benefit from reduced rates. Under the amended Directive, member states will be able to apply either reduced or zero rates to both vaccines and testing kits if they so choose.

The coronavirus pandemic has demanded an extraordinary response from authorities in all policy areas. The Commission is now intensifying work to prepare for the roll-out of new vaccines in the EU - in particular following recent ground-breaking announcements by global pharmaceutical players.

EU taxation and customs policy will continue to play an integral role in providing access to these crucial medical supplies, while also ensuring the safety of the goods that reach the internal market.

Next steps

Advertisement

To allow an immediate response from Member States, the rules will apply from the day after their publication in the Official Journal of the European Union. They will remain in place until the end of 2022, or until an agreement is reached on the Commission's pending proposal for new rules on VAT rates, if the latter occurs earlier.

More information

TAXUD news item

Proposal for a Council Directive amending Council Directive 2006/112/EC as regards temporary measures in relation to value added tax for COVID-19 vaccines and in vitro diagnostic medical devices in response to the COVID-19 pandemic

Communication on additional COVID-19 response measures and press release on coronavirus resurgence

 

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending